Travis K. Warren, Ph.D.

Operations Director
(Contractor)

Contact: For contact information, search the NIH Enterprise Directory.
Portrait of Travis K. Warren, Ph.D.

Biography

With over 20 years of experience conducting and leading infectious disease research, Dr. Warren’s data from nonclinical studies have contributed to U.S. Food and Drug Administration (FDA) approvals of tecoviromat for treatment of smallpox and remdesivir for treatment of SARS-CoV-2. He specializes in animal rule regulatory model characterizations and therapeutic development for highly infectious viral pathogens. He possesses extensive expertise in managing U.S. government-funded biocontainment assets to advance public-private partnerships with focus toward advanced development of medical countermeasures.